The efficacy and tolerability of risedronate once a week for the treatment of postmenopausal osteoporosis. [electronic resource]
Producer: 20030204Description: 103-11 p. digitalISSN:- 0171-967X
- Administration, Oral
- Aged
- Biomarkers -- analysis
- Bone Density
- Bone Resorption -- metabolism
- Calcium Channel Blockers -- administration & dosage
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Administration Schedule
- Etidronic Acid -- administration & dosage
- Female
- Femur Neck -- drug effects
- Humans
- Lumbar Vertebrae -- drug effects
- Middle Aged
- Osteoporosis, Postmenopausal -- drug therapy
- Risedronic Acid
- Spinal Fractures -- prevention & control
- Stomach -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.